ICON PLC (ICLR)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $14.58B
Last updated: Nov 17, 2026 at 11:06 AM ET
ICON PLC (ICLR) Competitors
The companies most similar to ICON are Charles River Laboratories (CRL), Medpace Holdings (MEDP) and Illumina (ILMN). ICON trades at 20.0x earnings, against a median of 31.8x for the 11 of these companies with a P/E. By market cap, ICON ranks 9th of the 13 companies on this page; IDEXX Laboratories (IDXX) is the largest at $55.48B.
Peer Comparison
ICLR's ROIC of 2.8% is below the peer median of 8.2%, and its revenue growth of -2.9% is below the median of 7.5%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| ICON (ICLR) | $14.58B | 20.0x | 1.8x | 5.3% | 2.8% | -2.9% | 0.00% |
| Charles River Laboratories (CRL) | $16.19B | 31.8x | 4.0x | 1.0% | 0.1% | -2.2% | 0.00% |
| Medpace Holdings Inc (MEDP) | $18.29B | 35.9x | 6.4x | 18.2% | N/A | 8.5% | 0.00% |
| Illumina Inc (ILMN) | $31.30B | 37.7x | 6.6x | 19.7% | 19.1% | 4.2% | 0.00% |
| IQVIA Holdings Inc (IQV) | $43.69B | 22.0x | 2.5x | 8.1% | 8.5% | 8.0% | 0.00% |
| Qiagen NV (QGEN) | $10.30B | 20.5x | 4.9x | 18.2% | 8.2% | 2.9% | 0.70% |
| Revvity Inc. (RVTY) | $17.24B | 26.8x | 5.6x | 8.6% | 3.4% | 4.3% | 0.19% |
| Quest Diagnostics Incorporated (DGX) | $28.56B | 23.8x | 2.4x | 9.5% | 10.2% | 10.0% | 1.31% |
| Labcorp Holdings Inc. (LH) | $30.08B | 20.6x | 2.1x | 6.9% | 8.2% | 6.9% | 0.77% |
| RadNet Inc (RDNT) | $6.02B | 141.5x | 2.5x | -0.9% | 2.7% | 22.1% | 0.00% |
| GRAIL, LLC (GRAL) | $5.21B | N/A | 29.6x | -243.8% | N/A | 3.7% | 0.00% |
| IDEXX Laboratories Inc (IDXX) | $55.48B | 47.3x | 11.8x | 25.4% | 44.3% | 9.9% | 0.00% |
| CareDx Inc (CDNA) | $4.09B | 48.2x | 6.4x | 25.9% | N/A | 39.3% | 0.00% |
| Peer median | $17.76B | 31.8x | 5.3x | 9.1% | 8.2% | 7.5% | 0.00% |
Similar Companies
These are the 12 companies most similar to ICON, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Diagnostics & Research.
| Company | About | Peers |
|---|---|---|
| Charles River Laboratories (CRL) | Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory... | CRL competitors |
| Medpace Holdings Inc (MEDP) | Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. | MEDP competitors |
| Illumina Inc (ILMN) | Illumina, Inc. is an American company. | ILMN competitors |
| IQVIA Holdings Inc (IQV) | IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology... | IQV competitors |
| Qiagen NV (QGEN) | QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. | QGEN competitors |
| Revvity Inc. (RVTY) | Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. | RVTY competitors |
| Quest Diagnostics Incorporated (DGX) | Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. | DGX competitors |
| Labcorp Holdings Inc. (LH) | Laboratory Corporation of America Holdings, more commonly known as Labcorp, is an American company headquartered in Burlington, North Carolina. | LH competitors |
| RadNet Inc (RDNT) | RadNet, Inc., provides outpatient imaging services in the United States. The company is headquartered in Los Angeles, California. | RDNT competitors |
| GRAIL, LLC (GRAL) | GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics... | GRAL competitors |
| IDEXX Laboratories Inc (IDXX) | IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture... | IDXX competitors |
| CareDx Inc (CDNA) | CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. | CDNA competitors |
Frequently Asked Questions About ICLR
Who are ICON's main competitors?
The companies most similar to ICON include Charles River Laboratories (CRL), Medpace Holdings (MEDP), Illumina (ILMN), IQVIA Holdings (IQV) and Qiagen NV (QGEN), listed from the closest match.
Who is ICON's biggest competitor?
IDEXX Laboratories (IDXX) is the largest of the similar companies at $55.48B; Charles River Laboratories (CRL) is the closest match by business profile, size, sector and industry.
How does ICLR stock compare with its competitors?
ICLR's P/E is 20.0x against a peer median of 31.8x; its P/S is 1.8x against a peer median of 5.3x; its net margin is 5.3% against a peer median of 9.1%.
Which of ICON's competitors pays a higher dividend?
ICON pays no dividend. Quest Diagnostics (DGX), Labcorp Holdings (LH), Qiagen NV (QGEN) and Revvity (RVTY) have higher forward dividend yields; Quest Diagnostics (DGX) has the highest at 1.31%.
Is ICON bigger than its competitors?
No. ICON is 9th by market cap among the 13 companies on this page; the largest is IDEXX Laboratories (IDXX) at $55.48B.
ICLR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors